DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
Official title: DiaFootCare to Promote Self-Care of Diabetic Foot Ulcers in Oman
Run by Oman Ministry of Health · NCT07815275 · Data updated 2026-11-12
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 80 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Oman Ministry of Health Government |
| Locations | 1 site (Muscat) |
| Status | Recruiting |
| Started | October 13, 2026 |
| Main results expected | June 13, 2027 |
| Study ends | June 13, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07815275 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30–80 with type 1 or type 2 diabetes and an active diabetic foot ulcer who own a compatible smartphone and can use the app after instruction, in Oman.
✕Probably not a fit
Patients without access to a compatible smartphone or who are unable to use the app due to impairment or lack of follow-up may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests the DiaFootCare mobile health app designed to educate patients, remind them about medications and care tasks, and monitor wounds with photos. Adults with diabetic foot ulcers receiving care at the National Diabetes and Endocrine Centre in Oman will be assigned to use DiaFootCare or continue with usual care. Outcomes will include self-care behaviors, medication adherence, glycemic control, wound healing, and user engagement with the app over three months. The trial will also assess usability and effectiveness of the app in supporting pharmacist-led monitoring and communication.
Why it matters
Potential benefit: If effective, DiaFootCare could improve self-management and healing of diabetic foot ulcers and enhance ongoing pharmacist support.
How similar studies have gone: Previous digital health and mHealth tools for chronic wounds have shown potential to support self-care and monitoring, but results vary by context and app design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Adults aged 30 to 80 years. * Diagnosed with type 1 or type 2 diabetes mellitus. * Have an active diabetic foot ulcer. * Have access to a compatible smartphone and internet connection. * Able to understand Arabic and use the DiaFootCare application after receiving instructions. * Willing and able to provide written informed consent and complete the three-month follow-up. Exclusion Criteria: * Severe cognitive, visual, physical, or communication impairment that prevents use of the application or completion of study assessments. * A diabetic foot condition requiring immediate hospitalization or urgent major surgical intervention. * Unable or unwilling to complete the three-month follow-up. * Concurrent participation in another intervention study that could affect the study outcomes.
Where it's running
-
National Diabetes and Endocrine Centre
Muscat, Oman Recruiting
Study contacts
- Study coordinator: Raqiya AL Mamari
- Email: raqiyaalmamari@gmail.com
- Phone: 0096896794009
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Combination Bionerv E+ vs Vitamin B Complex in Type 2 Diabetes with DSPN and Foot Ulcers
In people with type 2 diabetes and diabetic polyneuropathy, this study tests whether adding alpha-lipoic acid and vitamin E to a vitamin B mix helps nerve symptoms and wound healing better than the vitamin B mix alone.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.